NCT00977431 2019-02-18Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma MultiformBoehringer IngelheimPhase 1 Completed36 enrolled 16 charts